MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

CorMedix Inc

Cerrado

SectorSanidad

11.32 0.71

Resumen

Variación precio

24h

Actual

Mínimo

11.22

Máximo

11.51

Métricas clave

By Trading Economics

Ingresos

7.2M

21M

Ventas

7.9M

39M

P/B

Media del Sector

45.68

39.564

Margen de beneficios

52.822

Empleados

64

EBITDA

7.2M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+71.37% upside

Dividendos

By Dow Jones

Próximas Ganancias

13 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

229M

865M

Apertura anterior

10.61

Cierre anterior

11.32

Noticias sobre sentimiento de mercado

By Acuity

89%

11%

361 / 376 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

9 jul 2025, 15:46 UTC

Principales Movimientos del Mercado

BitMine Shares Fall After Closing of $250 Million Private Placement

9 jul 2025, 23:44 UTC

Charlas de Mercado

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9 jul 2025, 23:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 jul 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9 jul 2025, 22:59 UTC

Charlas de Mercado

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9 jul 2025, 22:59 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

9 jul 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

9 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 jul 2025, 20:26 UTC

Ganancias

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9 jul 2025, 19:18 UTC

Charlas de Mercado

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9 jul 2025, 19:03 UTC

Charlas de Mercado

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9 jul 2025, 18:31 UTC

Charlas de Mercado

Some Fed Officials Supported Considering July Cut -- Market Talk

9 jul 2025, 17:07 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9 jul 2025, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk -2-

9 jul 2025, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 jul 2025, 16:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

9 jul 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

9 jul 2025, 16:14 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 jul 2025, 16:14 UTC

Charlas de Mercado

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9 jul 2025, 16:14 UTC

Adquisiciones, fusiones, absorciones

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9 jul 2025, 16:12 UTC

Charlas de Mercado

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9 jul 2025, 16:08 UTC

Charlas de Mercado

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9 jul 2025, 15:31 UTC

Principales Movimientos del Mercado

BitMine Shares Fall After Closing of $250M Private Placement

9 jul 2025, 15:31 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9 jul 2025, 15:27 UTC

Charlas de Mercado

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9 jul 2025, 14:36 UTC

Adquisiciones, fusiones, absorciones

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9 jul 2025, 14:31 UTC

Adquisiciones, fusiones, absorciones

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 jul 2025, 14:26 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

9 jul 2025, 14:26 UTC

Charlas de Mercado

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

71.37% repunte

Estimación a 12 Meses

Media 19.33 USD  71.37%

Máximo 20 USD

Mínimo 18 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

361 / 376 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.